Add BrightSurf on Google Email

Sniffing our way to better health

Researchers have discovered that certain volatile compounds emitted by microbes and food can alter epigenetic states in neurons and other eukaryotic cells. Exposure to these compounds can slow down neurodegeneration and cancer, while also affecting plant growth and responses to stress.

SourceUniversity of California - Riverside·JournaleLife·TypeExperimental study·DateFeb 27, 2024

One step forward, no steps back: new study advances understanding of dopamine’s role in movement

Researchers discover dopamine signals affect movement sequence length, shedding light on Parkinson's Disease symptoms and potential therapeutic targets. The study's findings suggest a complex role of dopamine neurons in movement, with distinct effects on movement-related and reward-related dopamine neurons.

SourceChampalimaud Centre for the Unknown·JournalCurrent Biology·TypeExperimental study·DateFeb 19, 2024

Understanding chronic wasting disease in deer

A new study from the University of Pennsylvania School of Veterinary Medicine sheds light on how Chronic Wasting Disease (CWD) impacts the gut microbiome, providing a potential tool for disease surveillance. Researchers found that certain types of gut bacteria can differentiate between CWD-positive and -negative deer.

SourceUniversity of Pennsylvania·JournalMicrobiology Spectrum·TypeExperimental study·DateFeb 12, 2024

Interferon-gamma drives brain pathology in a mouse model of multiple system atrophy

In a mouse model of multiple system atrophy, alpha-synuclein overexpression induces neuroinflammation, demyelination, and neurodegeneration. IFNγ produced by infiltrating CD4+ T-cells mediates these changes. The study suggests that IFNγ is a potential future disease-modifying therapeutic target.

SourceUniversity of Alabama at Birmingham·JournalActa Neuropathologica Communications·TypeExperimental study·DateFeb 12, 2024

Mapping the structure and organization of hippocampal neurons in the mouse brain

A new study maps the spatial organization of hippocampal neurons in the mouse brain, revealing previously unknown principles. The researchers created a comprehensive three-dimensional single-cell atlas of the region and its connections, which will aid in understanding the neural circuitry and underlying brain functions.

Organ donations after MAiD made up 14% of deceased donations in Quebec

A new study in the Canadian Medical Association Journal found that organ donations after medical assistance in dying (MAiD) represented 14% of all deceased organ donations in Quebec in 2022. The majority of donors had neurodegenerative diseases, with amyotrophic lateral sclerosis being the most common condition.

SourceCanadian Medical Association Journal·JournalCanadian Medical Association Journal·TypeObservational study·DateJan 29, 2024

Pusan National University researchers decode the link between smoking and amyotrophic lateral sclerosis risk

Researchers from Pusan National University found a notable association between smoking and an increased risk of Amyotrophic Lateral Sclerosis (ALS), particularly among female smokers. The study revealed a dose-response relationship, with the risk peaking at moderate to heavy smoking levels.

SourcePusan National University·JournalTobacco Induced Diseases·TypeSystematic review·DateJan 29, 2024

CityU neuroscientists uncover the therapeutic potential of low-dose ionizing radiation for traumatic brain injury and ischemic stroke

Researchers found that low-dose X-ray irradiation reduced lesion size and reversed motor deficits in TBI and ischemic stroke mice, demonstrating its potential as a therapeutic strategy. The treatment also accelerated substantial motor function recovery and promoted brain rewiring after stroke.

SourceCity University of Hong Kong·JournalBrain Behavior and Immunity·TypeExperimental study·DateJan 26, 2024

Bioengineers on the brink of breaching blood-brain barrier

A team of researchers has devised a method to deliver mRNA into the brain using lipid nanoparticles, offering new hope for treating conditions like Alzheimer's disease and seizures. The approach uses a special keycard-like system to bypass the blood-brain barrier, allowing therapeutic agents to enter the brain and target specific cells.

SourceUniversity of Pennsylvania·JournalNano Letters·TypeExperimental study·DateJan 23, 2024

Towards a new Parkinson's diagnosis: Introduction of the SynNeurGe biological diagnosis classification

A new biological classification system for Parkinson's disease, known as SynNeurGe (S-N-G system), has been introduced. This classification considers three key components: pathological α-synuclein in tissues or cerebrospinal fluid, neuroimaging techniques, and pathogenic gene variants. The S-N-G system offers a detailed framework for u...

SourceUniversity of Lübeck·JournalThe Lancet Neurology·TypeMeta-analysis·DateJan 22, 2024

A “radically different” way of looking at Parkinson’s Disease

Scientists propose a new biologically-based classification system for Parkinson's disease, considering three biological factors: pathologic α-synuclein, neurodegeneration, and gene variants. This 'S-N-G' system aims to better understand the complex biology of PD and identify subgroups with distinct disease processes.

SourceUniversity Health Network·JournalThe Lancet Neurology·TypeComputational simulation/modeling·DateJan 22, 2024

Progression of ALS linked to a membrane and an enzyme: mitochondria-endoplasmic reticulum disruption and loss of TBK1 activity

Researchers at Nagoya University have discovered a relationship between ALS progression and the disruption of mitochondria-associated membranes (MAM) and TBK1 activity. Decreased activation of TBK1 is linked to motor neuron death in ALS patients and mice with disrupted MAM.

SourceNagoya University·JournalProceedings of the National Academy of Sciences·DateJan 17, 2024

Inspired by Greek mythology, this potential drug shows promise for vanquishing Parkinson’s RNA in early studies

A potential Parkinson's medicine, Syn-RiboTAC, targets RNA to slow or stop disease progression by preventing the buildup of toxic protein alpha-synuclein. In early studies, reducing alpha-synuclein levels by even 25% or more is therapeutically beneficial, with the compound showing good selectivity and improved brain-barrier penetration.

SourceUF Health·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateJan 9, 2024

Can we fight back against Parkinson’s disease? These research volunteers hope so

Researchers at Boston University's Center for Neurorehabilitation have made two important advances that may help people with Parkinson's disease walk more smoothly. Wearable soft robotic apparel and a music-based technology were tested in studies, showing promising results in increasing walking duration and distance.

SourceBoston University·JournalNature Medicine·TypeRandomized controlled/clinical trial·DateJan 5, 2024

Evidence early, but emerging, that gamma rhythm stimulation can treat neurological disorders

A growing number of studies have found that non-invasive sensory, electrical, or magnetic stimulation of gamma brain rhythms can reduce Alzheimer's pathology and its consequences. These studies have shown increases in gamma power, brain network connectivity, and improvements in memory, cognition, and sleep.

SourcePicower Institute at MIT·JournalJournal of Internal Medicine·TypeLiterature review·DateDec 20, 2023

AI-driven breakthroughs in cells study: SFU-UBC collaboration introduces "MCS-detect" for advancements in super-resolution microscopy

Researchers from SFU and UBC introduce MCS-DETECT, an AI-driven algorithm that detects membrane contact sites in large microscopy volumes without segmentation. This innovation enhances super-resolution microscopy capabilities, contributing to a better understanding of cellular interactions and complex diseases.

SourceSimon Fraser University·JournalJournal of Cell Biology·DateDec 8, 2023

New source of stem cells in injury-affected brains of patients

Researchers at Helmholtz Munich have identified a new source of stem cells in the brains of patients with brain injuries, which could lead to improved treatments for neurological disorders. The discovery involves specific astrocyte cells that exhibit properties of neural stem cells and can be regulated by a protein called Galectin 3.

When physics meets biology: prion protein orchestrates liquid-liquid phase separation with copper

Researchers discovered that prion protein and copper form sticky droplets under oxidative stress, leading to abnormal solid formation. The study highlights the biological significance of liquid-liquid phase separation in regulating copper homeostasis by PrP.

Coverage of Bruce Willis’ frontotemporal degeneration shows media misconstrues the disease

A new paper reveals that media coverage of Bruce Willis' condition was inaccurate, with journalists misrepresenting the relationship between aphasia and frontotemporal degeneration. The disease was often described as if it were a separate disorder from aphasia, when in fact aphasia is a symptom of frontotemporal degeneration.

SourceOxford University Press USA·JournalInnovation in Aging·TypeLiterature review·DateDec 1, 2023

Scientists produce human norepinephrine neurons from stem cells, with significant implications for researching diseases like Alzheimer’s and Parkinson’s

Researchers at the University of Wisconsin-Madison have successfully generated human norepinephrine neurons from stem cells using a key protein called ACTIVIN-A. These LC-NE neurons may serve as models for disease in humans, enabling scientists to screen drugs and answer questions about neurodegeneration.

SourceUniversity of Wisconsin-Madison·JournalNature Biotechnology·DateNov 17, 2023

Chemical process makes peptide acquire structure similar to amyloid plaques found in neurodegenerative diseases

Scientists identify pyroglutamination, a spontaneous chemical change, in peptide synthesis, leading to an amyloidal structure and potential implications for neurodegenerative diseases like Alzheimer's and Parkinson's. The process favors aggregation of molecules, forming plaques that interrupt neuronal flow.

B12 deficiency: a hidden trigger of inflammation?

A recent study found a compelling link between vitamin B12 deficiency and chronic inflammation, which can lead to various health problems. The research revealed an inverse relationship between vitamin B12 levels and inflammatory markers in humans and mice, suggesting that higher vitamin B12 levels may lower inflammatory markers.

SourceSociety of Chemical Industry·JournalJournal of the Science of Food and Agriculture·TypeObservational study·DateOct 17, 2023

Research in the Special Issue of Journal of Pharmaceutical Analysis uncovers previously unexplored cellular mechanisms

Researchers have discovered new insights into microglia-astrocyte communication and its impact on intracerebral hemorrhage, as well as the testicular toxicity of triptolide. Additionally, a study on epicardial cells has identified key gene markers associated with cardiac regenerative therapy strategies.

SourceCactus Communications·JournalJournal of Pharmaceutical Analysis·TypeExperimental study·DateOct 16, 2023